FDA's first Digital Health AdComm meeting mulls promises & perils of Generative AI
JD Supra Risk Management: As with any new technology, implementation of Gen AI capabilities requires careful consideration of benefits andrisks. Industry …
Read the original at JDSupra ↗
- Topics
- HealthcareGovernance & Risk Management
- Mentions
- FDA
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”